Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 6/2023

29.11.2022

Sex differences in outcomes of transvenous lead extraction: insights from National Readmission Database

verfasst von: Mahmoud Khalil, Muhammad Haisum Maqsood, Ahmed Maraey, Ahmed Elzanaty, Ayman Saeyeldin, Kenneth Ong, Chirag R. Barbhaiya, Larry A. Chinitz, Scott Bernstein, Mohamed Shokr

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

With the growing use of implantable cardiac devices, the need for transvenous lead extraction has increased, which translates to increased procedural volumes. Sex differences in lead extraction outcomes are not well studied.

Objective

The present study aims at evaluating the impact of sex on outcomes of lead extraction.

Methods

We identified 71,754 patients who presented between 2016 and 2019 and underwent transvenous lead extraction. Their clinical data were retrospectively accrued from the National Readmission Database (NRD) using the corresponding diagnosis codes. We compared clinical outcomes between male and female patients. Odds ratios (ORs) for the primary and secondary outcomes were calculated, and multivariable regression analysis was utilized to adjust for confounding variables.

Results

Compared to male patients, female patients had higher in-hospital complications including pneumothorax (OR 1.26, 95% CI (1.07–1.4), P < 0.01), hemopericardium (OR 1.39, 95% CI (1.02–1.88), P = 0.036), injury to superior vena cava and innominate vein requiring repair (OR 1.88, 95% CI (1.14–3.1), P = 0.014; OR 3.4, 95% CI (1.8–6.5), P < 0.01), need for blood transfusion (OR 1.28, 95% CI (1.18–1.38), P < 0.01), and pericardiocentesis (OR 1.6, 95% CI (1.3–2), P < 0.01). Thirty-day readmission was also significantly higher in female patients (OR 1.09, 95% CI (1.02–1.17), P < 0.01). There was no significant difference regarding in-hospital mortality (OR 0.99, 95% CI (0.87–1.14), P = 0.95).

Conclusion

In female patients, lead extraction is associated with worse clinical outcomes and higher 30-day readmission rate.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. J Am Coll Cardiol. 2012;60(16):1540–5.CrossRefPubMed Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. J Am Coll Cardiol. 2012;60(16):1540–5.CrossRefPubMed
2.
Zurück zum Zitat Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14(12):e503–51.CrossRefPubMed Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14(12):e503–51.CrossRefPubMed
3.
Zurück zum Zitat Brunner MP, Cronin EM, Duarte VE, Yu C, Tarakji KG, Martin DO, et al. Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions. Heart Rhythm. 2014;11(5):799–805.CrossRefPubMed Brunner MP, Cronin EM, Duarte VE, Yu C, Tarakji KG, Martin DO, et al. Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions. Heart Rhythm. 2014;11(5):799–805.CrossRefPubMed
4.
Zurück zum Zitat Wazni O, Epstein LM, Carrillo RG, Love C, Adler SW, Riggio DW, et al. Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol. 2010;55(6):579–86.CrossRefPubMed Wazni O, Epstein LM, Carrillo RG, Love C, Adler SW, Riggio DW, et al. Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol. 2010;55(6):579–86.CrossRefPubMed
5.
Zurück zum Zitat Byrd CL, Wilkoff BL, Love CJ, Sellers TD, Turk KT, Reeves R, et al. Intravascular extraction of problematic or infected permanent pacemaker leads: 1994–1996. U.S. Extraction Database, MED Institute. Pacing Clin Electrophysiol. 1999;22(9):1348–57.CrossRefPubMed Byrd CL, Wilkoff BL, Love CJ, Sellers TD, Turk KT, Reeves R, et al. Intravascular extraction of problematic or infected permanent pacemaker leads: 1994–1996. U.S. Extraction Database, MED Institute. Pacing Clin Electrophysiol. 1999;22(9):1348–57.CrossRefPubMed
6.
Zurück zum Zitat Bongiorni MG, Kennergren C, Butter C, Deharo JC, Kutarski A, Rinaldi CA, et al. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes. Eur Heart J. 2017;38(40):2995–3005.CrossRefPubMed Bongiorni MG, Kennergren C, Butter C, Deharo JC, Kutarski A, Rinaldi CA, et al. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes. Eur Heart J. 2017;38(40):2995–3005.CrossRefPubMed
7.
Zurück zum Zitat Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129(1):125–37.CrossRefPubMed Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129(1):125–37.CrossRefPubMed
8.
Zurück zum Zitat Elzanaty AM, Maraey A, Elbadawi A, Khalil M, Hashim A, Vyas R, et al. Early versus late discharge after transcatheter aortic valve replacement and readmissions for permanent pacemaker implantation. Catheteriz Cardiovas Intervent Off J Soc Cardiac Angiograph Interv. 2022. Elzanaty AM, Maraey A, Elbadawi A, Khalil M, Hashim A, Vyas R, et al. Early versus late discharge after transcatheter aortic valve replacement and readmissions for permanent pacemaker implantation. Catheteriz Cardiovas Intervent Off J Soc Cardiac Angiograph  Interv. 2022.
9.
Zurück zum Zitat Leuven E, Sianesi B. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing. 2018. Leuven E, Sianesi B. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing. 2018.
10.
Zurück zum Zitat Wilkoff BL, Byrd CL, Love CJ, Hayes DL, Sellers TD, Schaerf R, et al. Pacemaker lead extraction with the laser sheath: results of the pacing lead extraction with the excimer sheath (PLEXES) trial. J Am Coll Cardiol. 1999;33(6):1671–6.CrossRefPubMed Wilkoff BL, Byrd CL, Love CJ, Hayes DL, Sellers TD, Schaerf R, et al. Pacemaker lead extraction with the laser sheath: results of the pacing lead extraction with the excimer sheath (PLEXES) trial. J Am Coll Cardiol. 1999;33(6):1671–6.CrossRefPubMed
11.
Zurück zum Zitat Issa ZF. Transvenous lead extraction in 1000 patients guided by intraprocedural risk stratification without surgical backup. Heart Rhythm. 2021;18(8):1272–8.CrossRefPubMed Issa ZF. Transvenous lead extraction in 1000 patients guided by intraprocedural risk stratification without surgical backup. Heart Rhythm. 2021;18(8):1272–8.CrossRefPubMed
12.
Zurück zum Zitat Deshmukh A, Patel N, Noseworthy PA, Patel AA, Patel N, Arora S, et al. Trends in Use and Adverse Outcomes Associated with Transvenous Lead Removal in the United States. Circulation. 2015;132(25):2363–71.CrossRefPubMed Deshmukh A, Patel N, Noseworthy PA, Patel AA, Patel N, Arora S, et al. Trends in Use and Adverse Outcomes Associated with Transvenous Lead Removal in the United States. Circulation. 2015;132(25):2363–71.CrossRefPubMed
13.
Zurück zum Zitat Bashir J, Lee AJ, Philippon F, Mondesert B, Krahn AD, Sadek MM, et al. Predictors of perforation during lead extraction: Results of the Canadian Lead ExtrAction Risk (CLEAR) study. Heart Rhythm. 2021. Bashir J, Lee AJ, Philippon F, Mondesert B, Krahn AD, Sadek MM, et al. Predictors of perforation during lead extraction: Results of the Canadian Lead ExtrAction Risk (CLEAR) study. Heart Rhythm. 2021.
14.
Zurück zum Zitat Sood N, Martin DT, Lampert R, Curtis JP, Parzynski C, Clancy J. Incidence and Predictors of Perioperative Complications With Transvenous Lead Extractions: Real-World Experience With National Cardiovascular Data Registry. Circ Arrhythm Electrophysiol. 2018;11(2): e004768.CrossRefPubMed Sood N, Martin DT, Lampert R, Curtis JP, Parzynski C, Clancy J. Incidence and Predictors of Perioperative Complications With Transvenous Lead Extractions: Real-World Experience With National Cardiovascular Data Registry. Circ Arrhythm Electrophysiol. 2018;11(2): e004768.CrossRefPubMed
15.
16.
Zurück zum Zitat Santangeli P, di Biase L, Pelargonio G, Natale A. Outcome of invasive electrophysiological procedures and gender: are males and females the same? J Cardiovasc Electrophysiol. 2011;22(5):605–12.CrossRefPubMed Santangeli P, di Biase L, Pelargonio G, Natale A. Outcome of invasive electrophysiological procedures and gender: are males and females the same? J Cardiovasc Electrophysiol. 2011;22(5):605–12.CrossRefPubMed
17.
Zurück zum Zitat Chen JF, Zafar MA, Wu J, Li Y, Rizzo JA, Papanikolaou D, et al. Increased Virulence of Descending Thoracic and Thoracoabdominal Aortic Aneurysms in Women. Ann Thorac Surg. 2021;112(1):45–52.CrossRefPubMed Chen JF, Zafar MA, Wu J, Li Y, Rizzo JA, Papanikolaou D, et al. Increased Virulence of Descending Thoracic and Thoracoabdominal Aortic Aneurysms in Women. Ann Thorac Surg. 2021;112(1):45–52.CrossRefPubMed
18.
Zurück zum Zitat Breathett K, Yee E, Pool N, Hebdon M, Crist JD, Yee RH, et al. Association of Gender and Race With Allocation of Advanced Heart Failure Therapies. JAMA Netw Open. 2020;3(7): e2011044.CrossRefPubMedPubMedCentral Breathett K, Yee E, Pool N, Hebdon M, Crist JD, Yee RH, et al. Association of Gender and Race With Allocation of Advanced Heart Failure Therapies. JAMA Netw Open. 2020;3(7): e2011044.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Kaiser DW, Fan J, Schmitt S, Than CT, Ullal AJ, Piccini JP, et al. Gender Differences in Clinical Outcomes after Catheter Ablation of Atrial Fibrillation. JACC Clin Electrophysiol. 2016;2(6):703–10.CrossRefPubMedPubMedCentral Kaiser DW, Fan J, Schmitt S, Than CT, Ullal AJ, Piccini JP, et al. Gender Differences in Clinical Outcomes after Catheter Ablation of Atrial Fibrillation. JACC Clin Electrophysiol. 2016;2(6):703–10.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Moore K, Ganesan A, Labrosciano C, Heddle W, McGavigan A, Hossain S, et al. Sex Differences in Acute Complications of Cardiac Implantable Electronic Devices: Implications for Patient Safety. J Am Heart Assoc. 2019;8(2): e010869.CrossRefPubMedPubMedCentral Moore K, Ganesan A, Labrosciano C, Heddle W, McGavigan A, Hossain S, et al. Sex Differences in Acute Complications of Cardiac Implantable Electronic Devices: Implications for Patient Safety. J Am Heart Assoc. 2019;8(2): e010869.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Zimetbaum P, Carroll BJ, Locke AH, Secemsky E, Schermerhorn M. Lead-Related Venous Obstruction in Patients With Implanted Cardiac Devices: JACC Review Topic of the Week. J Am Coll Cardiol. 2022;79(3):299–308.CrossRefPubMed Zimetbaum P, Carroll BJ, Locke AH, Secemsky E, Schermerhorn M. Lead-Related Venous Obstruction in Patients With Implanted Cardiac Devices: JACC Review Topic of the Week. J Am Coll Cardiol. 2022;79(3):299–308.CrossRefPubMed
22.
Zurück zum Zitat Abu-El-Haija B, Bhave PD, Campbell DN, Mazur A, Hodgson-Zingman DM, Cotarlan V, et al. Venous Stenosis After Transvenous Lead Placement: A Study of Outcomes and Risk Factors in 212 Consecutive Patients. J Am Heart Assoc. 2015;4(8): e001878.CrossRefPubMedPubMedCentral Abu-El-Haija B, Bhave PD, Campbell DN, Mazur A, Hodgson-Zingman DM, Cotarlan V, et al. Venous Stenosis After Transvenous Lead Placement: A Study of Outcomes and Risk Factors in 212 Consecutive Patients. J Am Heart Assoc. 2015;4(8): e001878.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Garate-Carrillo A, Gonzalez J, Ceballos G, Ramirez-Sanchez I, Villarreal F. Sex related differences in the pathogenesis of organ fibrosis. Transl Res. 2020;222:41–55.CrossRefPubMedPubMedCentral Garate-Carrillo A, Gonzalez J, Ceballos G, Ramirez-Sanchez I, Villarreal F. Sex related differences in the pathogenesis of organ fibrosis. Transl Res. 2020;222:41–55.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Polewczyk A, Rinaldi CA, Sohal M, Golzio PG, Claridge S, Cano O, et al. Transvenous lead extraction procedures in women based on ESC-EHRA EORP European Lead Extraction ConTRolled ELECTRa registry: is female sex a predictor of complications? Europace. 2019;21(12):1890–9.PubMed Polewczyk A, Rinaldi CA, Sohal M, Golzio PG, Claridge S, Cano O, et al. Transvenous lead extraction procedures in women based on ESC-EHRA EORP European Lead Extraction ConTRolled ELECTRa registry: is female sex a predictor of complications? Europace. 2019;21(12):1890–9.PubMed
25.
Zurück zum Zitat Khan SS, Nessim S, Gray R, Czer LS, Chaux A, Matloff J. Increased mortality of women in coronary artery bypass surgery: evidence for referral bias. Ann Intern Med. 1990;112(8):561–7.CrossRefPubMed Khan SS, Nessim S, Gray R, Czer LS, Chaux A, Matloff J. Increased mortality of women in coronary artery bypass surgery: evidence for referral bias. Ann Intern Med. 1990;112(8):561–7.CrossRefPubMed
26.
Zurück zum Zitat Pepi M, Muratori M, Barbier P, Doria E, Arena V, Berti M, et al. Pericardial effusion after cardiac surgery: incidence, site, size, and haemodynamic consequences. Br Heart J. 1994;72(4):327–31.CrossRefPubMedPubMedCentral Pepi M, Muratori M, Barbier P, Doria E, Arena V, Berti M, et al. Pericardial effusion after cardiac surgery: incidence, site, size, and haemodynamic consequences. Br Heart J. 1994;72(4):327–31.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Patel D, Sripariwuth A, Abozeed M, Hussein AA, Tarakji KG, Wazni OM, et al. Lead Location as Assessed on Cardiac Computed Tomography and Difficulty of Percutaneous Transvenous Extraction. JACC Clin Electrophysiol. 2019;5(12):1432–8.CrossRefPubMed Patel D, Sripariwuth A, Abozeed M, Hussein AA, Tarakji KG, Wazni OM, et al. Lead Location as Assessed on Cardiac Computed Tomography and Difficulty of Percutaneous Transvenous Extraction. JACC Clin Electrophysiol. 2019;5(12):1432–8.CrossRefPubMed
28.
Zurück zum Zitat Paul SD, Eagle KA, Guidry U, DiSalvo TG, Villarreal-Levy G, Smith AJ, et al. Do gender-based differences in presentation and management influence predictors of hospitalization costs and length of stay after an acute myocardial infarction? Am J Cardiol. 1995;76(16):1122–5.CrossRefPubMed Paul SD, Eagle KA, Guidry U, DiSalvo TG, Villarreal-Levy G, Smith AJ, et al. Do gender-based differences in presentation and management influence predictors of hospitalization costs and length of stay after an acute myocardial infarction? Am J Cardiol. 1995;76(16):1122–5.CrossRefPubMed
Metadaten
Titel
Sex differences in outcomes of transvenous lead extraction: insights from National Readmission Database
verfasst von
Mahmoud Khalil
Muhammad Haisum Maqsood
Ahmed Maraey
Ahmed Elzanaty
Ayman Saeyeldin
Kenneth Ong
Chirag R. Barbhaiya
Larry A. Chinitz
Scott Bernstein
Mohamed Shokr
Publikationsdatum
29.11.2022
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 6/2023
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-022-01438-z

Weitere Artikel der Ausgabe 6/2023

Journal of Interventional Cardiac Electrophysiology 6/2023 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.